Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.

Sahores A, Figueroa V, May M, Liguori M, Rubstein A, Fuentes C, Jacobsen BM, Elía A, Rojas P, Sequeira GR, Álvarez MM, González P, Gass H, Hewitt S, Molinolo A, Lanari C, Lamb CA.

Horm Cancer. 2018 Jun 28. doi: 10.1007/s12672-018-0339-4. [Epub ahead of print]

PMID:
29956066
2.

MRP4/ABCC4 as a new therapeutic target: meta-analysis to determine cAMP binding sites as a tool for drug design.

Yaneff A, Sahores A, Gomez N, Carozzo A, Shayo C, Davio C.

Curr Med Chem. 2017 Dec 29. doi: 10.2174/0929867325666171229133259. [Epub ahead of print]

PMID:
29284392
3.

Targeting FGFR with BGJ398 in breast cancer: Effect on tumor growth and metastasis.

Sahores A, May M, Sequeira G, Fuentes C, Jacobsen B, Lanari C, Lamb CA.

Curr Cancer Drug Targets. 2017 Dec 13. doi: 10.2174/1568009618666171214114706. [Epub ahead of print]

PMID:
29237381
4.

FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.

Langle YV, Belgorosky D, Prack McCormick B, Sahores A, Góngora A, Baldi A, Lanari C, Lamb C, Eiján AM.

J Urol. 2016 Jan;195(1):188-97. doi: 10.1016/j.juro.2015.06.093. Epub 2015 Jul 2.

PMID:
26144336
5.

Novel, low cost, highly effective, handmade steroid pellets for experimental studies.

Sahores A, Luque GM, Wargon V, May M, Molinolo A, Becu-Villalobos D, Lanari C, Lamb CA.

PLoS One. 2013 May 15;8(5):e64049. doi: 10.1371/journal.pone.0064049. Print 2013.

6.

Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer.

Cerliani JP, Vanzulli SI, Piñero CP, Bottino MC, Sahores A, Nuñez M, Varchetta R, Martins R, Zeitlin E, Hewitt SM, Molinolo AA, Lanari C, Lamb CA.

Breast Cancer Res Treat. 2012 Jun;133(3):997-1008. doi: 10.1007/s10549-011-1883-6. Epub 2011 Nov 29.

PMID:
22124578
7.

Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia.

Cerliani JP, Giulianelli S, Sahores A, Wargon V, Gongora A, Baldi A, Molinolo A, Lamb CE, Lanari C.

Medicina (B Aires). 2010;70(6):529-32.

PMID:
21163742
8.

Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth.

Fabris VT, Sahores A, Vanzulli SI, Colombo L, Molinolo AA, Lanari C, Lamb CA.

BMC Cancer. 2010 Jun 16;10:293. doi: 10.1186/1471-2407-10-293.

9.

Bone mineral density in patients with cervical and trochanteric fractures of the proximal femur.

Vega E, Mautalen C, Gómez H, Garrido A, Melo L, Sahores AO.

Osteoporos Int. 1991 Feb;1(2):81-6.

PMID:
1790397
10.

[Comminuted fracture of the upper jaw: clinical cases].

Sahores AO, Cáceres AD, González EG.

Rev Circ Odontol Sur. 1969;8:21-2. Spanish. No abstract available.

PMID:
5282323

Supplemental Content

Loading ...
Support Center